Comparison of Survival Rates Between Patients Treated with Conventional Radiotherapy and Helical Tomotherapy for Head and Neck Cancer

Overview

Journal Radiat Oncol J

Specialty Oncology

Date 2013 Apr 27

PMID 23620863

Citations 9

Authors

Moonkyoo Kong

Seong Eon Hong

Jinhyun Choi

Youngkyong Kim

Affiliations

Soon will be listed here.

Abstract

Purpose: Compared to conventional radiotherapy (RT), intensity-modulated radiotherapy (IMRT) significantly reduces the rate of treatment-induced late toxicities in head and neck cancer. However, a clear survival benefit of IMRT over conventional RT has not yet been shown. This study is among the first comparative study to compare the survival rates between conventional RT and helical tomotherapy in head and neck cancer.

Materials And Methods: From January 2008 to November 2011, 37 patients received conventional RT and 30 patients received helical tomotherapy for management of head and neck cancer. We retrospectively compared the survival rates between patients treated with conventional RT and helical tomotherapy, and analyzed the prognostic factors for survival.

Results: The 1- and 2-year locoregional recurrence-free survival rates were 61.2% and 58.1% for the conventional RT group, 89.3% and 80.3% for the helical tomotherapy group, respectively. The locoregional recurrence-free survival rates of the helical tomotherapy group were significantly higher than conventional RT group (p = 0.029). There were no significant differences in the overall and distant metastasis-free survival between the two groups. RT technique, tumor stage, and RT duration were significant prognostic factors for locoregional recurrence-free survival.

Conclusion: This study showed the locoregional recurrence-free survival benefits of helical tomotherapy in the treatment of head and neck cancers.

Citing Articles

Systematic Review of Genetic Polymorphisms Associated with Acute Pain Induced by Radiotherapy for Head and Neck Cancers.

Salama V, Geng Y, Rigert J, Fuller C, Shete S, Moreno A Clin Transl Radiat Oncol. 2023; 43:100669.

PMID: 37954025 PMC: 10634655. DOI: 10.1016/j.ctro.2023.100669.

Application of red light phototherapy in the treatment of radioactive dermatitis in patients with head and neck cancer.

Zhang X, Li H, Li Q, Li Y, Li C, Zhu M World J Surg Oncol. 2018; 16(1):222.

PMID: 30419911 PMC: 6233368. DOI: 10.1186/s12957-018-1522-3.

Concurrent Chemoradiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma: Treatment Outcomes and Prognostic Factors.

Kong M, Lim Y, Kim Y Asian Pac J Cancer Prev. 2018; 19(6):1591-1599.

PMID: 29936784 PMC: 6103582. DOI: 10.22034/APJCP.2018.19.6.1591.

The effect of clove-based herbal mouthwash on radiation-induced oral mucositis in patients with head and neck cancer: a single-blind randomized preliminary study.

Kong M, Hwang D, Yoon S, Kim J Onco Targets Ther. 2016; 9:4533-8.

PMID: 27524909 PMC: 4966496. DOI: 10.2147/OTT.S108769.

Volumetric modulated arc radiotherapy of the whole larynx, followed by a single affected vocal cord, for T1a glottic cancer: Dosimetric analysis of a case.

Yeo S Mol Clin Oncol. 2016; 4(3):429-432.

PMID: 26998298 PMC: 4774457. DOI: 10.3892/mco.2016.732.

References

Clark C, Bidmead A, Mubata C, Harrington K, Nutting C . Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother Oncol. 2004; 70(2):189-98. DOI: 10.1016/j.radonc.2003.10.012. View

Traynor A, Richards G, Hartig G, Khuntia D, Cleary J, Wiederholt P . Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience. Head Neck. 2009; 32(5):599-606. PMC: 3028434. DOI: 10.1002/hed.21224. View

Yu J, Soulos P, Sharma R, Makarov D, Decker R, Smith B . Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2012; 83(1):e101-7. DOI: 10.1016/j.ijrobp.2011.11.067. View

Fiorino C, DellOca I, Pierelli A, Broggi S, De Martin E, Di Muzio N . Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol. 2006; 78(3):276-82. DOI: 10.1016/j.radonc.2006.02.009. View

Chen A, Li B, Farwell D, Marsano J, Vijayakumar S, Purdy J . Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin. Int J Radiat Oncol Biol Phys. 2010; 79(3):756-62. DOI: 10.1016/j.ijrobp.2009.11.020. View

Gestel D, Van den Weyngaert D, Schrijvers D, Weyler J, Vermorken J . Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience. Br J Radiol. 2011; 84(1000):367-74. PMC: 3473465. DOI: 10.1259/bjr/67058055. View

Chao K, Ozyigit G, Tran B, Cengiz M, Dempsey J, Low D . Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003; 55(2):312-21. DOI: 10.1016/s0360-3016(02)03940-8. View

Fowler J . The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989; 62(740):679-94. DOI: 10.1259/0007-1285-62-740-679. View

Chen W, Hwang T, Wang W, Lu C, Chen C, Chen C . Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity. Oral Oncol. 2008; 45(6):505-10. DOI: 10.1016/j.oraloncology.2008.07.002. View

10.

Vergeer M, Doornaert P, Rietveld D, Leemans C, Slotman B, Langendijk J . Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys. 2008; 74(1):1-8. DOI: 10.1016/j.ijrobp.2008.07.059. View

11.

Yao M, Karnell L, Funk G, Lu H, Dornfeld K, Buatti J . Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2007; 69(5):1354-60. DOI: 10.1016/j.ijrobp.2007.05.003. View

12.

Bhide S, Ahmed M, Newbold K, Harrington K, Nutting C . The role of intensity modulated radiotherapy in advanced oral cavity carcinoma. J Cancer Res Ther. 2012; 8 Suppl 1:S67-71. DOI: 10.4103/0973-1482.92218. View

13.

Sheng K, Molloy J, Read P . Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: a comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy. Int J Radiat Oncol Biol Phys. 2006; 65(3):917-23. DOI: 10.1016/j.ijrobp.2006.02.038. View

14.

Chen A, Jennelle R, Sreeraman R, Yang C, Liu T, Vijayakumar S . Initial clinical experience with helical tomotherapy for head and neck cancer. Head Neck. 2009; 31(12):1571-8. DOI: 10.1002/hed.21123. View

15.

Orlandi E, Palazzi M, Pignoli E, Fallai C, Giostra A, Olmi P . Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review. Crit Rev Oncol Hematol. 2009; 73(2):111-25. DOI: 10.1016/j.critrevonc.2009.03.003. View

16.

Rades D, Fehlauer F, Wroblesky J, Albers D, Schild S, Schmidt R . Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. Oral Oncol. 2006; 43(6):535-43. DOI: 10.1016/j.oraloncology.2006.05.006. View

17.

Chao K, Low D, Perez C, Purdy J . Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience. Int J Cancer. 2000; 90(2):92-103. DOI: 10.1002/(sici)1097-0215(20000420)90:2<92::aid-ijc5>3.0.co;2-9. View

18.

Yao M, Dornfeld K, Buatti J, Skwarchuk M, Tan H, Nguyen T . Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Int J Radiat Oncol Biol Phys. 2005; 63(2):410-21. DOI: 10.1016/j.ijrobp.2005.02.025. View

19.

Madani I, Vakaet L, Bonte K, Boterberg T, De Neve W . Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer. Int J Radiat Oncol Biol Phys. 2008; 71(4):1158-66. DOI: 10.1016/j.ijrobp.2007.11.059. View

20.

Toledano I, Graff P, Serre A, Boisselier P, Bensadoun R, Ortholan C . Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03. Radiother Oncol. 2012; 103(1):57-62. DOI: 10.1016/j.radonc.2011.12.010. View